Professional Experience
Dr. Borges holds the position of Medical Doctor at the Champalimaud Clinical Centre, a leading institution in Lisbon renowned for its innovative approach to cancer treatment and research. He is actively involved in the Digestive Surgery and HPB Surgery departments, contributing to the development of advanced surgical protocols and patient care strategies. While specific numbers of surgeries performed are not publicly available, his role in a high-volume, specialized center underscores his extensive clinical experience.
Academic Contributions
- Regular contributor to international conferences on surgical oncology and HPB surgery.
- Collaborator in multicenter studies aimed at improving surgical outcomes in digestive cancer patients.
- Active participant in the Botton–Champalimaud Pancreatic Cancer Centre, contributing to global research initiatives in pancreatic cancer.
Areas of Expertise
Dr. Borges specializes in the surgical management of complex digestive cancers, with particular expertise in:
- Pancreatic Cancer: Surgical resection and management of pancreatic ductal adenocarcinoma.
- Hepatobiliary Surgery: Treatment of liver and bile duct malignancies.
- Minimally Invasive Surgery: Utilization of laparoscopic and robotic techniques to reduce patient recovery time.
- Surgical Oncology: Comprehensive management of gastrointestinal malignancies.
Publications and Research
Dr. Borges has co-authored numerous peer-reviewed articles in reputable medical journals, contributing to the field of surgical oncology. Notable publications include:
- Preoperative Inflammatory Scores Do Not Accurately Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma After Resection: A Systematic Review and Meta-Analysis (October 2024) – A study evaluating the reliability of preoperative inflammatory markers in predicting recurrence in pancreatic cancer patients.
- Evaluation of Quality and Quantity of Randomized Controlled Trials in Hepatobiliary Surgery: A Scoping/Mapping Review (April 2024) – An analysis of the current landscape of randomized controlled trials in HPB surgery.
- Defining Benchmarks for Total and Distal Gastrectomy: Global Multicentre Analysis (January 2024) – A collaborative effort to establish global standards for gastrectomy procedures.
Patient Care Philosophy
Dr. Borges is dedicated to providing compassionate, patient-centered care. He emphasizes clear communication and shared decision-making, ensuring that patients are well-informed and actively involved in their treatment plans. His approach is characterized by:
- Personalized treatment strategies tailored to individual patient needs.
- Commitment to minimizing surgical risks through advanced techniques.
- Focus on post-operative recovery and quality of life.
Professional Affiliations
- Member of the European Society of Surgical Oncology (ESSO).
- Active participant in international surgical oncology conferences and workshops.
- Contributor to multicenter research initiatives in HPB surgery.
FAQs
- Is Dr. Borges board-certified?
- Yes, Dr. Borges is board-certified in Digestive Surgery and Hepato-Pancreato-Biliary Surgery.
- What types of surgeries does he perform?
- Dr. Borges specializes in surgeries for pancreatic, liver, and bile duct cancers, including laparoscopic and robotic-assisted procedures.
- Does he treat international patients?
- Yes, the Champalimaud Clinical Centre welcomes international patients and provides comprehensive support for their care.
- How long is the typical hospital stay?
- The length of hospital stay varies depending on the complexity of the surgery and individual patient recovery, with efforts made to minimize hospitalization through advanced surgical techniques.
- What languages does he speak?
- Dr. Borges is proficient in Portuguese and English, facilitating communication with a diverse patient population.
